Skip Navigation

International Journal of Epidemiology 2008 37(1):57-59; doi:10.1093/ije/dym267
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Greenland, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Greenland, S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published by Oxford University Press on behalf of the International Epidemiological Association © The Author 2008; all rights reserved.

Commentary: Addressing Corporate Influence Through Ethical Guidelines

Sander Greenland

Department of Epidemiology and Department of Statistics, University of California, Los Angeles, USA.

E-mail: lesdomes@ucla.edu

Accepted 4 September 2007

The first 10% of the full text of this article appears below.

In light of Dr Pearce's theme, I must begin with full disclosure: I regard several of the epidemiologists who challenged his original fenoterol studies1 as first-rate and sincere in their original criticisms. What is more, I consult for one of them in his capacity as Distinguished Research Scientist at Boehringer-Ingelheim. Thus, I am a paid consultant for the very company that, 20 years ago, committed the acts that Dr Pearce describes in his book.1 Furthermore, I have conducted and published corporate-funded research to assess workplace and product hazards (e.g. see refs2,3).

Yet in all major respects I agree with Dr Pearce's comments. I support declarations of conflict of interest and mandatory disclosure of funding sources. I think . . . [Full Text of this Article]


   Observation 1: Individuals within corporations are heterogeneous
 

   Observation 2: Units within corporations can be heterogeneous
 

   Observation 3: Corporations are externally heterogeneous
 

   Societal Guidelines and the Legal System
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Epidemiol. Community HealthHome page
S. Greenland
Accounting for uncertainty about investigator bias: disclosure is informative: How could disclosure of interests work better in medicine, epidemiology and public health?
J Epidemiol Community Health, August 1, 2009; 63(8): 593 - 598.
[Full Text] [PDF]

Home page
 Int J EpidemiolHome page
G. Davey Smith
Big business, big science?
Int. J. Epidemiol., February 1, 2008; 37(1): 1 - 3.
[Full Text] [PDF]

Home page
 Int J EpidemiolHome page
N. Pearce
Response: The distribution and determinants of epidemiologic research
Int. J. Epidemiol., February 1, 2008; 37(1): 65 - 68.
[Full Text] [PDF]